StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Aditya Agarwal, Coheron Brokers

BUYDr. Reddy's Laboratories Limited

byAditya Agarwal, Coheron BrokersHorizon: 1–3 months21 Sept 2026via Business Today

Entry₹1,200Inferred
Target₹1,300
Total upside +8.33%
Stop lossNot given
CMP₹1,2116h ago
Active+0.92%+7.35%upside left 3 mo left
Follow Aditya Agarwal for new calls(41% target hit, 17 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 4 other Short-term calls on DRREDDYSee 64 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Sept, 10:17 pm IST
6 supporting2 opposing
Supports the BUY call (6)

MACD above its signal line — bullish momentum

Technicals · macd·22 Sept · today

10 advisors have active long-term BUY calls on this stock, with 4 issued in the last 14 days

Advisor consensus · adjacent horizon·21 Sept · yesterday

Dr. Reddy's Laboratories has entered into an exclusive distribution and marketing agreement with Takeda Biopharmaceuticals India for Qdenga®, a dengue vaccine, in the private market in India. The agre

BSE · Company Update·18 Sept · 4d ago

(opens in new tab)

3 other SEBI-registered advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·17 Sept · 5d ago

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?

NewsEt-Markets·16 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·10 Sept · 2w ago

(opens in new tab)

5 advisors have active long-term SELL calls on this stock

Advisor consensus · adjacent horizon·23 Jul · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.